Arteriosclerosis, Vol 9, 405-411, Copyright © 1989 by American Heart Association

ARTICLES

Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins

A Steinmetz, C Jakobs, S Motzny and H Kaffarnik
Zentrum Innere Medizin, Endokrinologie und Stoffwechsel, Philipps- Universitat, Marburg, West Germany.

The polymorphism of apolipoprotein E (apo E) accounts for a substantial amount of the genetic variance of cholesterol levels in man. The epsilon-2 allele and the epsilon-4 allele raises plasma and low density lipoprotein cholesterol levels as compared to the epsilon-3 allele. Whereas the lower cholesterol levels in carriers of the epsilon-2 allele can, at least in part, be attributed to the grossly deficient binding of apo E-2 to the apo B,E receptor, apo E-3 and E-4 bind to the same degree. We used gel filtration and ultracentrifugation to separate lipoproteins and subsequent immunoblotting analysis to study the apo E isoform distribution. We always found lipoproteins of lower density relatively enriched in apo E-4 and high density lipoproteins relatively depleted of apo E-4 as compared to apo E-3. This was also seen in plasma of heterozygous subjects that simultaneously express two apo E isoforms. Also, the apo E-A-II complex was directly shown by immunoblotting. Furthermore, when purified iodinated apo E was incubated with plasma in vitro, apo E-4 also reassociated more with lipoproteins of lower density than apo E-3. We conclude that apo E-3 and apo E-4 have a different lipoprotein particle distribution in vivo. This differential lipoprotein distribution may account for differences in the metabolism between apo E-3 and E-4.

This article has been cited by other articles:

				G. Ramaswamy, Q. Xu, Y. Huang, and K. H. Weisgraber Effect of Domain Interaction on Apolipoprotein E Levels in Mouse Brain J. Neurosci., November 16, 2005; 25(46): 10658 - 10663. [Abstract] [Full Text] [PDF]

				J. Drury and V. Narayanaswami Examination of Lipid-bound Conformation of Apolipoprotein E4 by Pyrene Excimer Fluorescence J. Biol. Chem., April 15, 2005; 280(15): 14605 - 14610. [Abstract] [Full Text] [PDF]

				J. Lee, C. S. Tan, K. S. Chia, C. E. Tan, S. K. Chew, J. M. Ordovas, and E. S. Tai The lipoprotein lipase S447X polymorphism and plasma lipids: interactions with APOE polymorphisms, smoking, and alcohol consumption J. Lipid Res., June 1, 2004; 45(6): 1132 - 1139. [Abstract] [Full Text] [PDF]

				P. C. R. Hopkins, Y. Huang, J. G. McGuire, and R. E. Pitas Evidence for differential effects of apoE3 and apoE4 on HDL metabolism J. Lipid Res., November 1, 2002; 43(11): 1881 - 1889. [Abstract] [Full Text] [PDF]

				D. Corella, M. Guillen, C. Saiz, O. Portoles, A. Sabater, J. Folch, and J. M. Ordovas Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: interaction with tobacco smoking and the APOE locus J. Lipid Res., March 1, 2002; 43(3): 416 - 427. [Abstract] [Full Text] [PDF]

				R. L. Raffai, L.-M. Dong, R. V. Farese Jr., and K. H. Weisgraber Introduction of human apolipoprotein E4 ""domain interaction"" into mouse apolipoprotein E PNAS, September 5, 2001; (2001) 201279298. [Abstract] [Full Text] [PDF]

				J. Dong, M. E. Balestra, Y. M. Newhouse, and K. H. Weisgraber Human apolipoprotein E7: lysine mutations in the carboxy-terminal domain are directly responsible for preferential binding to very low density lipoproteins J. Lipid Res., November 1, 2000; 41(11): 1783 - 1789. [Abstract] [Full Text]

				F. K. Welty, A. H. Lichtenstein, P. H. R. Barrett, J. L. Jenner, G. G. Dolnikowski, and E. J. Schaefer Effects of ApoE Genotype on ApoB-48 and ApoB-100 Kinetics With Stable Isotopes in Humans Arterioscler Thromb Vasc Biol, July 1, 2000; 20(7): 1807 - 1810. [Abstract] [Full Text] [PDF]

				H. Hamanaka, Y. Katoh-Fukui, K. Suzuki, M. Kobayashi, R. Suzuki, Y. Motegi, Y. Nakahara, A. Takeshita, M. Kawai, K. Ishiguro, et al. Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice Hum. Mol. Genet., February 12, 2000; 9(3): 353 - 361. [Abstract] [Full Text] [PDF]

				R. W. Mahley, Y. Huang, and S. C. Rall , Jr. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes J. Lipid Res., November 1, 1999; 40(11): 1933 - 1949. [Abstract] [Full Text]

				K. Yamauchi, M. Tozuka, H. Hidaka, E. Hidaka, Y. Kondo, and T. Katsuyama Characterization of Apolipoprotein E-containing Lipoproteins in Cerebrospinal Fluid: Effect of Phenotype on the Distribution of Apolipoprotein E Clin. Chem., September 1, 1999; 45(9): 1431 - 1438. [Abstract] [Full Text] [PDF]

				M. Orth, W. Weng, H. Funke, A. Steinmetz, G. Assmann, M. Nauck, J. Dierkes, A. Ambrosch, K. H. Weisgraber, R. W. Mahley, et al. Effects of a Frequent Apolipoprotein E Isoform, ApoE4Freiburg (Leu28->Pro), on Lipoproteins and the Prevalence of Coronary Artery Disease in Whites Arterioscler Thromb Vasc Biol, May 1, 1999; 19(5): 1306 - 1315. [Abstract] [Full Text] [PDF]

				T. Yamamura, L.-M. Dong, and A. Yamamoto Characterization of apolipoprotein E7 (Glu244'Lys, Glu245'Lys), a mutant apolipoprotein E associated with hyperlipidemia and atherosclerosis J. Lipid Res., February 1, 1999; 40(2): 253 - 259. [Abstract] [Full Text]

				L. Krimbou, M. Tremblay, J. Davignon, and J. S. Cohn Association of apolipoprotein E with {alpha}2-macroglobulin in human plasma J. Lipid Res., December 1, 1998; 39(12): 2373 - 2386. [Abstract] [Full Text]

				A. L. Biere, B. Ostaszewski, E. R. Stimson, B. T. Hyman, J. E. Maggio, and D. J. Selkoe Amyloid beta -Peptide Is Transported on Lipoproteins and Albumin in Human Plasma J. Biol. Chem., December 20, 1996; 271(51): 32916 - 32922. [Abstract] [Full Text] [PDF]

				J. G. Terry, G. Howard, M. Mercuri, M. G. Bond, and J. R. Crouse III Apolipoprotein E Polymorphism Is Associated With Segment-Specific Extracranial Carotid Artery Intima-Media Thickening Stroke, October 1, 1996; 27(10): 1755 - 1759. [Abstract] [Full Text]

				L.-M. Dong and K. H. Weisgraber Human Apolipoprotein E4 Domain Interaction. ARGININE 61AND GLUTAMIC ACID 255INTERACT TO DIRECT THE PREFERENCE FOR VERY LOW DENSITY LIPOPROTEINS J. Biol. Chem., August 9, 1996; 271(32): 19053 - 19057. [Abstract] [Full Text] [PDF]

				J. S. Cohn, M. Tremblay, M. Amiot, D. Bouthillier, M. Roy, J. Genest Jr, and J. Davignon Plasma Concentration of Apolipoprotein E in Intermediate-Sized Remnant-Like Lipoproteins in Normolipidemic and Hyperlipidemic Subjects Arterioscler Thromb Vasc Biol, January 1, 1996; 16(1): 149 - 159. [Abstract] [Full Text]

				E. M. Castao, F. Prelli, M. Pras, and B. Frangione Apolipoprotein E Carboxyl-terminal Fragments Are Complexed to Amyloids A and L J. Biol. Chem., July 21, 1995; 270(29): 17610 - 17615. [Abstract] [Full Text] [PDF]

				S. Fazio and Z. Yao The Enhanced Association of Apolipoprotein E With Apolipoprotein B–Containing Lipoproteins in Serum-Stimulated Hepatocytes Occurs Intracellularly Arterioscler Thromb Vasc Biol, May 1, 1995; 15(5): 593 - 600. [Abstract] [Full Text]

				D. M. Dreon, H. A. Fernstrom, B. Miller, and R. M. Krauss Apolipoprotein E Isoform Phenotype and LDL Subclass Response to a Reduced-Fat Diet Arterioscler Thromb Vasc Biol, January 1, 1995; 15(1): 105 - 111. [Abstract] [Full Text]

				R. L. Raffai, L.-M. Dong, R. V. Farese Jr., and K. H. Weisgraber Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E PNAS, September 25, 2001; 98(20): 11587 - 11591. [Abstract] [Full Text] [PDF]